Non-immunogenic Recombinant Staphylokinase vs Placebo in Patients With Intermediate High-risk Pulmonary Embolism

NCT06362746 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

486

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Embolism

Interventions

DRUG: Non-immunogenic recombinant staphylokinase
DRUG: Placebo

Sponsor

Supergene, LLC